Long-term exposure to dehydroepiandrosterone affects the transcriptional activity of the glucocorticoid receptor

Journal of Steroid Biochemistry and Molecular Biology

Volumn 103, Issue 2, 2007, Pages 129-136

  Saponaro, Sara ^a,b   Guarnieri, Vincenzo ^a,b   Pescarmona, Gian Piero ^a,b   Silvagno, Francesca ^a,b  

^a UNIVERSITY OF TURIN   (Italy)

^b MOLINETTE HOSPITAL   (Italy)

Author keywords

Dexamethasone; DHEA; EMSA; Glucocorticoid receptor; Nuclear translocation; TUBO cells

Indexed keywords

DEXAMETHASONE; DNA; GENE PRODUCT; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; PRASTERONE;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; IN VITRO STUDY; LONG TERM EXPOSURE; MOUSE; NONHUMAN; NUCLEAR IMPORT; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN TRANSPORT; PROTO ONCOGENE; RECEPTOR DOWN REGULATION; REGULATORY MECHANISM; REPORTER GENE; TRANSCRIPTION REGULATION; TRANSCRIPTOMICS;

ANIMALS; DEHYDROEPIANDROSTERONE; DNA-BINDING PROTEINS; MICE; MODELS, BIOLOGICAL; PROTEIN TRANSPORT; RECEPTORS, GLUCOCORTICOID; TIME; TRANS-ACTIVATION (GENETICS); TUMOR CELLS, CULTURED;

MOUSE MAMMARY TUMOR VIRUS;

EID: 33846444390     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2006.08.003     Document Type: Article

References (38)

1. Buckingham J.C. Glucocorticoids: exemplars of multi-tasking. Br. J. Pharmacol. 147 (2006) S258-S268
2. Bledsoe R.K., Stewart E.L., and Pearce K.H. Structure and function of the glucocorticoid receptor ligand binding domain. Vitam. Horm. 68 (2004) 49-91
3. Wright B.E., Porter J.R., Browne E.S., and Svec F. Antiglucocorticoid action of dehydroepiandrosterone in young obese Zucker rats. Int. J. Obes. Relat. Metab. Disord. 16 (1992) 579-583
4. Aoki K., Taniguchi H., Ito Y., Satoh S., Nakamura S., Muramatsu K., Yamashita R., Ito S., Mori Y., and Sekihara H. Dehydroepiandrosterone decreases elevated hepatic glucose production in C57BL/KsJ-db/db mice. Life Sci. 74 (2004) 3075-3084
5. Blauer K.L., Poth M., Rogers W.M., and Bernton E.W. Dehydroepiandrosterone antagonises the suppressive effects of dexamethasone on lymphocyte proliferation. Endocrinology 129 (1991) 3174-3179
6. Kalimi M., Shafagoj Y., Loria R., Padgett D., and Regelson W. Antiglucocorticoid effects of dehydroepiandrosterone (DHEA). Mol. Cell. Biochem. 131 (1994) 99-104
7. Daynes R.A., Araneo B.A., Hennebold J., Enioutina J., and Mu H.H. Steroids as regulators of the mammalian immune response. J. Invest. Dermatol. 105 (1995) 14S-19S
8. Morfin R. Involvement of steroids and cytochromes P(450) species in the triggering of immune defenses. J. Steroid Biochem. Mol. Biol. 80 (2002) 273-290
9. Muller C., Cluzeaud F., Pinon G.M., Rafestin-Oblin M., and Morfin R. Dehydroepiandrosterone and its 7-hydroxylated metabolites do not interfere with the transactivation and cellular trafficking of the glucocorticoid receptor. J. Steroid Biochem. Mol. Biol. 92 (2004) 469-476
10. Cardounel A., Regelson W., and Kalimi M. Dehydroepiandrosterone protects hippocampal neurons against neurotoxin-induced cell death: mechanism of action. Proc. Soc. Exp. Biol. Med. 222 (1999) 145-149
11. Boggio K., Nicoletti G., Di Carlo E., Cavallo F., Landuzzi L., Melani C., Giovarelli M., Rossi I., Nanni P., De Giovanni C., Bouchard P., Wolf S., Modesti A., Musiani P., Lollini P.L., Colombo M.P., and Forni G. Interleukin 12-mediated prevention of spontaneous mammary adenocarcinomas in two lines of Her-2/neu transgenic mice. J. Exp. Med. 188 (1998) 589-596
12. Rovero S., Amici A., Di Carlo E., Bei R., Nanni P., Quaglino E., Porcedda P., Boggio K., Smorlesi A., Lollini P., Landuzzi L., Colombo M.P., Giovarelli M., Musiani P., and Forni G. DNA vaccination against rat Her-2/Neu p185 more effectively inhibits carcinogenesis than transplantable carcinomas in transgenic BALB/c mice. J. Immunol. 165 (2000) 5133-5142
13. Baer M., Williams S.C., Dillner A., Schwartz R.C., and Johnson P.F. Autocrine signals control CCAAT/enhancer binding protein beta expression, localization, and activity in macrophages. Blood 92 (1998) 4353-4365
14. Silvagno F., Xia H., and Bredt D.S. Neuronal nitric-oxide synthase-mu, an alternatively spliced isoform expressed in differentiated skeletal muscle. J. Biol. Chem. 271 (1996) 11204-11208
15. Di Fulvio M., Lincoln T.M., Lauf P.K., and Ad ragna N.C. Protein kinase G regulates potassium chloride cotransporter-3 expression in primary cultures of rat vascular smooth muscle cells. J. Biol. Chem. 276 (2001) 21046-21052
16. Silvagno F., Guarnieri V., Capizzi A., and Pescarmona G.P. Synergistic effect of retinoic acid and dehydroepiandrosterone on differentiation of human neuroblastoma cells. FEBS Lett. 532 (2002) 153-158
17. Tanaka H., Dong Y., Li Q., Okret S., and Gustafsson J.A. Identification and characterization of a cis-acting element that interferes with glucocorticoid-inducible activation of the mouse mammary tumor virus promoter. Proc. Natl. Acad. Sci. USA 88 (1991) 5393-5397
18. Dong Y., Poellinger L., Gustafsson J.A., and Okret S. Regulation of glucocorticoid receptor expression: evidence for transcriptional and post-translational mechanisms. Mol. Endocrinol. 2 (1988) 1256-1264
19. Marcel J.M., and Schaaf J.A.C. Molecular mechanisms of glucocorticoid action and resistance. J. Steroid Biochem. Mol. Biol. 83 (2003) 37-48
20. Dillon J.S., Yaney G.C., Zhou Y., Voilley N., Bowen S., Chipkin S., Bliss C.R., Schultz V., Schuit F.C., Prentki M., Waxman D.J., and Corkey B.E. Dehydroepiandrosterone sulfate and beta-cell function: enhanced glucose-induced insulin secretion and altered gene expression in rodent pancreatic beta-cells. Diabetes 49 (2000) 2012-2020
21. Ménard S., Casalini P., Campiglio M., Pupa S.M., and Tagliabue E. Role of HER2/neu in tumor progression and therapy. Cell. Mol. Life Sci. 61 (2004) 2965-2978
22. Chen R., Burke T.F., Cumberland J.E., Brummet M., Beck L.A., Casolaro V., and Georas S.B. Glucocorticoids inhibit calcium- and calcineurin-dependent activation of the human IL-4 promoter. J. Immunol. 164 (2000) 825-832
23. Mandrekar P., Bellerose G., and Szabo G. Inhibition of NF-kB binding correlates with increased nuclear glucocorticoid receptor levels in acute alcohol-treated human monocytes. Alcohol Clin. Exp. Res. 26 (2002) 1872-1879
24. Loria R.M., Padgett D.A., and Huynh P.N. Regulation of the immune response by dehydroepiandrosterone and its metabolites. J. Endocrinol. 150 (1996) S209-S220
25. Daynes R., Dudley D., and Araneo B. Regulation of murine lymphokine production in vivo: II. Dehydroepiandrosterone is a natural enhancer of IL-2 synthesis by help T cells. Eur. J. Immunol. 20 (1990) 793-801
26. Padgett D.A., and Loria R.M. Endocrine regulation of murine macrophage function: effects of dehydroepiandrosterone, androstenediol, and androstenetriol. J. Neuroimmunol. 84 (1998) 61-68
27. Svec F., and Porter J.R. The actions of exogenous dehydroepiandrosterone in experimental animals and humans. Proc. Soc. Exp. Biol. Med. 218 (1998) 174-191
28. Tokunaga E., Oki E., Nishida K., Koga T., Egashira A., Morita M., Kakeji Y., and Maehara Y. Trastuzumab and breast cancer: developments and current status. Int. J. Clin. Oncol. 11 (2006) 199-208
29. Yip Y.L., Smith G., Koch J., Dübel S., and Ward R.L. Identification of epitope regions recognized by tumor inhibitory and stimulatory anti-ErbB-2 monoclonal antibodies: implications for vaccine design. J. Immunol. 166 (2001) 5271-5278
30. Pariante C.M., Pearce B.D., Pisell T.L., Su C., and Miller A.H. The steroid receptor antagonists RU40555 and RU486 activate glucocorticoid receptor translocation and are not excreted by the steroid hormones transporter in L929 cells. J. Endocrinol. 169 (2001) 309-320
31. Schaaf M.J.M., and Cidlowski J.A. Molecular determinants of glucocorticoid receptor mobility in living cells: the importance of ligand affinity. Mol. Cell. Biol. 23 (2003) 1922-1934
32. Qi M., Stasenko L.J., and DeFranco D.B. Recycling and desensitization of glucocorticoid receptors in v-mos transformed cells depend on the ability of nuclear receptors to modulate gene expression. Mol. Endocrinol. 4 (1990) 455-464
33. Beck C.A., Estes P.A., Bona B.J., Muro-Cacho C.A., Nordeen S.K., and Edwards D.P. The steroid antagonist RU486 exerts different effects on the glucocorticoid and progesterone receptors. Endocrinology 133 (1993) 728-740
34. Stevens A., Garside H., Berry A., Waters C., White A., and Ray D. Dissociation of steroid receptor coactivator 1 and nuclear receptor corepressor recruitment to the human glucocorticoid receptor by modification of the ligand-receptor interface: the role of tyrosine 735. Mol. Endocrinol. 17 (2003) 845-859
35. Schulz M., Eggert M., Baniahmad A., Dostert A., Heinzel T., and Renkawitz R. RU486-induced glucocorticoid receptor agonism is controlled by the receptor N terminus and by corepressor binding. J. Biol. Chem. 277 (2002) 26238-26243
36. Faivre E., Skildum A., Pierson-Mullany L., and Lange C.A. Integration of progesterone receptor mediated rapid signaling and nuclear actions in breast cancer cell models: role of mitogen-activated protein kinases and cell cycle regulators. Steroids 70 (2005) 418-426
37. Ialenti A., Grassia G., Di Meglio P., Maffia P., Di Rosa M., and Ianaro A. Mechanism of the anti-inflammatory effect of thiazolidinediones: relationship with the glucocorticoid pathway. Mol. Pharmacol. 67 (2005) 1620-1628
38. Zhao J., Bauman W.A., Huang R., Caplan A.J., and Cardozo C. Oxandrolone blocks glucocorticoid signaling in an androgen receptor-dependent manner. Steroids 69 (2004) 357-366